Clinical Trials Directory

Trials / Completed

CompletedNCT06570018

Short Term Outcome Following Post Operative Enhanced Recovery Implementation in Patients With Perforated Peptic Ulcer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aimed to evaluate the effect of implementing post operative enhanced recovery on perforated peptic ulcer surgery outcome. The current study anticipated better outcomes in the form of early functional recovery, reduced length of hospital stays, less thirty days post operative morbidity, and better gastrointestinal quality of life after implementing post operative enhanced recovery in patients with perforated peptic ulcer.

Detailed description

This study aimed to evaluate the effect of implementing post operative enhanced recovery on perforated peptic ulcer surgery outcomes. Methods: Quasi- experimental research design was utilized. The study was conducted at Assiut University Hospital. A purposive sample of thirty patients (study group) who received postoperative enhanced recovery after open surgical repair of perforated peptic ulcer compared with thirty patients (control group) who exposed to routine care. patient assessment sheet and gastrointestinal quality of life index were the tools used for data collection.

Conditions

Interventions

TypeNameDescription
PROCEDUREPost operative enhanced recovery elementsAccording to the study group the researchers collaborated with surgeons, nurses, and anesthesiologists to implement post operative enhanced recovery protocol that defined clearly in the following elements Early nutrition, Early mobilization, Non-opioid analgesia. Early removal of abdominal drains and tubes throughout the patients' hospital stay up to their discharge.

Timeline

Start date
2023-10-01
Primary completion
2024-07-15
Completion
2024-08-15
First posted
2024-08-26
Last updated
2025-01-29

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06570018. Inclusion in this directory is not an endorsement.